Treatment Information

Back

Brain – Glioblastoma Multiforme treatment details. Biologic therapy.

Cleveland Clinic, Cleveland, OH, United States.

Survival: monthsCountry:United States
Toxiciy Grade:4City/State/Province:Cleveland, OH
Treatments:Biologic therapyHospital:Cleveland Clinic
Drugs:Journal:Link
Date:Apr 2013

Description:

Patients:
This phase 2 study involved 56 recurrent or progressive glioblastoma patients. The median patient age was 56 years and 63% were male.

Treatment:
Patients were treated with the biologic therapy agents erlotinib and sorafenib, which are kinase inhibitors that interfere with tumor growth.

Toxicities:
The most severe toxicities were grade 3-4 fatigue and pancreatic problems.

Results:
The median overall survival was 5.7 months.

Correspondence: Dr. David M. Peereboom; email: [email protected]



Back